Liang, L., Wen, Y., Hu, R., Wang, L., Xia, Y., Hu, C., … Jiang, X. (2019). Safety and efficacy of PD-1 blockade-activated multiple antigen-specific cellular therapy alone or in combination with apatinib in patients with advanced solid tumors: a pooled analysis of two prospective trials. Cancer Immunology, Immunotherapy : CII, 68(9), 1467-1477. https://doi.org/10.1007/s00262-019-02375-z (Original work published 2019)
Apatinib
Zhou, Y., Li, M., Zhang, B., Yang, C., Wang, Y., Zheng, S., … Yao, Y. (2023). A pilot study of multi-antigen stimulated cell therapy-I plus camrelizumab and apatinib in patients with advanced bone and soft-tissue sarcomas. BMC Medicine, 21(1), 470. https://doi.org/10.1186/s12916-023-03132-x (Original work published 2023)